CNTN2 and lung cancer: This study demonstrates that a combination of COP or its major constituent BER with chemotherapeutic drugs including 5-FU, CPT, and TAX exhibits a stronger inhibitory effect on the growth of A549 human lung cancer cells than any individual treatment.